HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.

Abstract
Topo IIalpha (topoisomerase IIalpha) is a major target of several commonly used anticancer drugs and is subject to down-regulation at the transcriptional level in some drug-resistant cell lines and tumours in response to chemotherapy. Clinical resistance to such drugs has been correlated with down-regulation of topo IIalpha at transcription in some drug-resistant cell lines and tumours. Putative binding sites for a variety of transcription factors, including Sp1 (specificity protein 1) and NF-Y (nuclear factor Y) have previously been identified in the topo IIalpha promoter, but their functional significance and interactions have not been described following exposure to anti-cancer drugs. The binding of these factors to specific putative regulatory elements in the topo IIalpha promoter was studied using electrophoretic-mobility-shift assays. Sp1 was found to bind strongly to both distal and proximal GC-rich elements and NF-Y to ICB1 (the first inverted CCAAT box). The functional significance of transcription-factor binding was studied using transient transfection of HeLa cells using a luciferase reporter driven by a 617-bp minimal promoter containing point mutations in putative regulatory elements. Sp1 and NF-Y were both found to be transcriptional modulators with activator or repressor functions depending on protein/DNA context. Moreover, a functional interaction between Sp1 and NF-Y bound at proximal elements was observed.
AuthorsNatisha Magan, Agnieszka P Szremska, Richard J Isaacs, Kathryn M Stowell
JournalThe Biochemical journal (Biochem J) Vol. 374 Issue Pt 3 Pg. 723-9 (Sep 15 2003) ISSN: 1470-8728 [Electronic] England
PMID12769819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • CCAAT-Binding Factor
  • DNA-Binding Proteins
  • Recombinant Fusion Proteins
  • Sp1 Transcription Factor
  • Transcription Factors
  • nuclear factor Y
  • Sp2 Transcription Factor
  • Luciferases
  • DNA Topoisomerases, Type II
Topics
  • Antigens, Neoplasm
  • CCAAT-Binding Factor (genetics, physiology)
  • DNA Topoisomerases, Type II (genetics, metabolism)
  • DNA-Binding Proteins (genetics, metabolism, physiology)
  • Electrophoretic Mobility Shift Assay
  • Gene Expression Regulation, Enzymologic
  • Genes, Reporter (genetics)
  • HeLa Cells
  • Humans
  • Luciferases (genetics)
  • Mutagenesis, Site-Directed
  • Promoter Regions, Genetic
  • Recombinant Fusion Proteins (genetics)
  • Sp1 Transcription Factor (genetics, physiology)
  • Sp2 Transcription Factor
  • Transcription Factors (genetics, physiology)
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: